Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
Clinical trial NCT06956235 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06956235
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2026-11-16
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.